Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
Kim M. van Pul, Marieke F. Fransen, Rieneke van de Ven, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 367
Vaccine delivery systems toward lymph nodes
Yingyue Ding, Zhaoting Li, Ana Jaklenec, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113914-113914
Open Access | Times Cited: 123
Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors
Laurel B. Darragh, Jacob Gadwa, Tiffany Pham, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 116
Challenges in developing personalized neoantigen cancer vaccines
Peter D. Katsikis, Ken J. Ishii, Christopher Schliehe
Nature reviews. Immunology (2023) Vol. 24, Iss. 3, pp. 213-227
Closed Access | Times Cited: 92
Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity
Siyuan You, Shuqin Li, Lingsu Zeng, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1415-1433.e12
Closed Access | Times Cited: 23
Regulation and impact of tumor-specific CD4+ T cells in cancer and immunotherapy
Mengdi Guo, M. Liu, David G. Brooks
Trends in Immunology (2024) Vol. 45, Iss. 4, pp. 303-313
Closed Access | Times Cited: 21
Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients
Tong Liu, Cheng Liu, Meisi Yan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 61
Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade
Ying Zhang, Raghava N. Sriramaneni, Paul A. Clark, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 53
Integrated Copper Nanomaterials‐Decorated Microsphere Photothermal Platform for Comprehensive Melanoma Treatment
Xinyi Zhang, Mengya Zhang, Hengqing Cui, et al.
Small Structures (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 13
Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation
Kim M. van Pul, Jessica C.L. Notohardjo, Marieke F. Fransen, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Closed Access | Times Cited: 36
Pivotal roles of tumor‐draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy
Zhaoyun Liu, Zhiyong Yu, Dawei Chen, et al.
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 971-986
Open Access | Times Cited: 29
Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions
Yueyi Li, Li Shen, Zedong Jiang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Systemic versus localized Bacillus Calmette Guérin immunotherapy of bladder cancer promotes an anti‐tumoral microenvironment: Novel role of trained immunity
Aline Atallah, Arielle Grossman, Richard W. Nauman, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 2, pp. 352-364
Open Access | Times Cited: 8
Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering
Jie Wang, Zongying Zhang, Rongxiang Liang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101068-101068
Open Access | Times Cited: 8
Lymph Nodes-On-Chip: Promising Immune Platforms for Pharmacological and Toxicological Applications
Aya Shanti, Nicholas Hallfors, Georg Petroianu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 37
Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
Harm Westdorp, Mark W. D. Sweep, Mark A.J. Gorris, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours
Lydia G. White, Hannah E. Goy, Alinor J. Rose, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 978-978
Open Access | Times Cited: 25
The cellular and molecular basis of CD69 function in anti-tumor immunity
Ryo Koyama‐Nasu, Yangsong Wang, Ichita Hasegawa, et al.
International Immunology (2022) Vol. 34, Iss. 11, pp. 555-561
Open Access | Times Cited: 25
Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy
Yao Wang, Tingting Zhu, Qi Shi, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008026-e008026
Open Access | Times Cited: 6
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
Hui Yuwen, Huajing Wang, Tengteng Li, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1680-1698
Open Access | Times Cited: 6
Focused Ultrasound‐Responsive Nanocomposite with Near‐Infrared II Mechanoluminescence for Spatiotemporally Selective Immune Activation in Lymph Nodes
Sixin Xu, Xiaohe Li, Qian Hu, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 19
Closed Access | Times Cited: 5
Mechanisms of lymph node metastasis: An extracellular vesicle perspective
Susana García‐Silva, Héctor Peinado
European Journal of Cell Biology (2024) Vol. 103, Iss. 3, pp. 151447-151447
Open Access | Times Cited: 5
Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors
Haitang Yang, Beibei Sun, Wenyan Ma, et al.
EBioMedicine (2022) Vol. 84, pp. 104265-104265
Open Access | Times Cited: 21
TGF-β-dependent lymphoid tissue residency of stem-like T cells limits response to tumor vaccine
Guo Li, Saranya Srinivasan, Liwen Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
Tynisha S. Rafael, Jossie Rotman, Oscar R. Brouwer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1101-1101
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top